MYGENVIII Trademark
MYGENVIII is a USPTO trademark filed by Bayer Atkiengesellschaft. Status: Registered.
Trademark Facts
| Mark | MYGENVIII |
|---|---|
| Serial Number | 90850017 |
| Registration Number | 6988714 |
| Status | Registered |
| Filing Date | 2021-07-27 |
| Registration Date | 2023-02-28 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Bayer Atkiengesellschaft |
| Attorney of Record | Phillip Barengolts |
| Prosecution Events | 20 |
| Latest Event | ARAA on 2024-12-17 |
Goods & Services
pharmaceutical products for the treatment of bleeding disorders; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of diabetes; anti-infectives; pharmaceutical products for use in cell and gene therapy for the treatment of bleeding disorders, cardiovascular diseases, cancer, diabetes, and infections